Dr. Lansing Taylor, PhD, Professor of Computational and Systems Biology, Director of the University of Pittsburgh Drug Discovery Institute

Dr. Lansing Taylor, PhD
Professor of Computational and Systems Biology
Director of the University of Pittsburgh Drug Discovery Institute

Dr. Taylor received his Ph.D. in cell biology from the State University of New York at Albany, and was a postdoctoral fellow in biophysics at the Woods Hole Marine Biological Laboratory. Dr. Taylor began his academic career as an Assistant Professor at Harvard University, was soon promoted to Associate Professor, remaining at Harvard until 1982; he then moved to Carnegie Mellon University as a Professor of Biological Sciences and to start the Center for Fluorescence Research in the Biomedical Sciences. Dr. Taylor developed a number of imaging technologies and fluorescence-based reagents while investigating the mechanisms of cell movements. Dr. Taylor has founded a number of life science companies including Biological Detection Systems, now part of GE Life Sciences, Cellomics, now part of Thermo Fisher and Cellumen, now part of Cyprotex.; and, most recently, Cernostics, a tissue systems biology/diagnostics company. He holds a substantial number of U.S. patents, including six focused on cell-based screening. Dr. Taylor held an NIH MERIT award from 1990-2000 and a Pioneer Award from the National Science Foundation, as well as several awards as "Entrepreneur of the Year."